Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in MYGN — Myriad Genetics Inc

CIK 1179392 NEW YORK, NY
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,894,621
+$3,116,396 QoQ
Shares Held
1,557,727
+21.3% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 196 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $734,488,194 across 28 Diagnostics & Research names. MYGN ranks #5 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 3,719,301 $558,006,729
2 DHR
Danaher Corp /De/
 452,752 $86,240,200
3 CDNA
CareDx, Inc.
 401,987 $11,456,629
4 IQV
Iqvia Holdings Inc.
 48,191 $9,311,465
5 MYGN
Myriad Genetics Inc
This page 		1,557,727 $8,894,621
6 NTRA
Natera, Inc.
 32,600 $8,849,270
7 TMO
Thermo Fisher Scientific Inc.
 17,014 $8,530,139
8 FLGT
Fulgent Genetics, Inc.
 400,986 $8,228,232

All Filings in MYGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,894,621 1,557,727
2026-03-31 $5,778,225 1,284,050
2025-12-31 $5,628,301 915,171
2025-09-30 $5,268,313 728,674
2025-06-30 $2,891,050 544,454
2025-03-31 $128,615 14,500
2024-03-31 $434,928 20,400
2023-12-31 $712,008 37,200
2023-09-30 $551,776 34,400
2023-06-30 $700,036 30,200
2023-03-31 $397,233 17,100
2022-12-31 $387,997 26,740
2021-06-30 $2,637,708 86,256
2021-03-31 $10,898,755 357,923
2020-12-31 $12,002,228 607,093
2020-09-30 $12,719,476 975,420
2020-06-30 $8,534,359 752,589
2020-03-31 $1,700,070 118,803